Group One Trading
TBPH icon

Group One Trading’s Theravance Biopharma TBPH Stock Holding History

Group One Trading’s Portfolio TBPH Stock Details TBPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.3M Buy
+80,200
New +$1.42M ﹤0.01% 2463
2025
Q4 		– Sell
-7,300
Closed -$107K – 9140
2025
Q3 		$107K Buy
+7,300
New +$92.2K ﹤0.01% 5283
2024
Q2 		– Sell
-200
Closed -$1.79K – 7468
2024
Q1 		$1.79K Buy
+200
New +$1.85K ﹤0.01% 6510
2023
Q3 		– Sell
-1,300
Closed -$13.5K – 8291
2023
Q2 		$13.5K Sell
1,300
-700
-35% -$7.73K ﹤0.01% 6224
2023
Q1 		$21.7K Buy
2,000
+900
+82% +$9.52K ﹤0.01% 5445
2022
Q4 		$12.3K Sell
1,100
-19,600
-95% -$206K ﹤0.01% 5916
2022
Q3 		$210K Buy
20,700
+20,600
+20,600% +$193K ﹤0.01% 4101
2022
Q2 		$1K Sell
100
-11,300
-99% -$104K ﹤0.01% 7624
2022
Q1 		$109K Buy
+11,400
New +$112K ﹤0.01% 5408
2021
Q4 		– Sell
-74,500
Closed -$551K – 8824
2021
Q3 		$551K Buy
+74,500
New +$833K ﹤0.01% 4083
2020
Q2 		– Sell
-5,000
Closed -$116K – 6163
2020
Q1 		$116K Buy
5,000
+3,000
+150% +$75.1K ﹤0.01% 3185
2019
Q4 		$52K Buy
+2,000
New +$38.9K ﹤0.01% 3986
2019
Q3 		– Sell
-76,800
Closed -$1.25M – 5540
2019
Q2 		$1.25M Buy
76,800
+26,800
+54% +$543K 0.01% 1444
2019
Q1 		$1.13M Buy
+50,000
New +$1.27M 0.01% 1320
2018
Q2 		– Sell
-200
Closed -$5K – 5464
2018
Q1 		$5K Buy
+200
New +$5.49K ﹤0.01% 4513
2017
Q4 		– Sell
-4,300
Closed -$147K – 5216
2017
Q3 		$147K Buy
+4,300
New +$141K ﹤0.01% 2986
2017
Q1 		– Sell
-2,500
Closed -$80K – 4989
2016
Q4 		$80K Sell
2,500
-14,600
-85% -$453K ﹤0.01% 2977
2016
Q3 		$620K Buy
17,100
+13,600
+389% +$379K 0.01% 1660
2016
Q2 		$79K Buy
+3,500
New +$75.6K ﹤0.01% 3025
2015
Q4 		– Sell
-90,000
Closed -$989K – 5091
2015
Q3 		$989K Buy
90,000
+88,800
+7,400% +$1.13M 0.01% 1252
2015
Q2 		$16K Buy
+1,200
New +$18.6K ﹤0.01% 4140

Other funds holding TBPH

MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $5.91B AUM 42.42% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ICM
Irenic Capital Management New York $1.54B AUM 12.79% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Group One Trading's TBPH Position: Q1 2026 in Review

Group One Trading increased its Theravance Biopharma (TBPH) stake by 1,282% in Q1 2026, buying an estimated $215K and bringing the position to 13,125 shares worth $213K. The position accounts for ﹤0.01% of the portfolio, ranked #4059.

Group One Trading first reported a position in TBPH in Q2 2014 and has held it in 23 quarters since. The position peaked at $973K in Q2 2019. 173 funds tracked by Wall St. Rank hold TBPH as of Q1 2026.

  • Group One Trading held 13,125 shares of Theravance Biopharma worth $213K as of Q1 2026.
  • Group One Trading bought 12,175 Theravance Biopharma shares in Q1 2026, an estimated $215K.
  • Theravance Biopharma made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #4059 holding.
  • Group One Trading first reported a position in Theravance Biopharma in Q2 2014 and has held it in 23 quarters since.
  • Group One Trading's Theravance Biopharma position peaked at $973K in Q2 2019.
  • 173 funds tracked by Wall St. Rank held Theravance Biopharma as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.